135-67-1 | Phenoxazine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$12.00	$8.00
5g	98%	in stock	$31.00	$22.00
10g	98%	in stock	$58.00	$41.00
25g	98%	in stock	$136.00	$95.00
100g	98%	in stock	$529.00	$370.00

Description

• Catalog Number: AB46856
• Chemical Name: Phenoxazine
• CAS Number: 135-67-1
• Molecular Formula: C12H9NO
• Molecular Weight: 183.206
• MDL Number: MFCD00005014
• SMILES: c1ccc2c(c1)Oc1c(N2)cccc1
• NSC Number: 72990

Computed Properties

• Complexity: 187
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• XLogP3: 3.9

Literature

• Efficient green thermally activated delayed fluorescence (TADF) from a phenoxazine-triphenyltriazine (PXZ-TRZ) derivative.

  Chemical communications (Cambridge, England) 20121204

• N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.

  Journal of medicinal chemistry 20121126

• High efficiency new hole injection materials for organic light emitting diodes based on dimeric phenothiazine and phenoxazine moiety derivatives.

  Journal of nanoscience and nanotechnology 20120501

• Transition-metal-free intramolecular N-arylations.

  Organic letters 20120406

• 4,6-Bis(diphenyl-phosphan-yl)-2,8-di-methyl-phenoxathiin dichloro-methane monosolvate.

  Acta crystallographica. Section E, Structure reports online 20120401

• Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.

  PloS one 20120101

• Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).

  Journal of medicinal chemistry 20111027

• Synthesis and in vitro antiprotozoal activities of 5-phenyliminobenzo[a]phenoxazine derivatives.

  Bioorganic & medicinal chemistry letters 20111001

• Brightly fluorescent purple and blue labels for amines and proteins.

  Bioorganic & medicinal chemistry letters 20110915

• Molecular modeling study of intercalation complexes of tricyclic carboxamides with d(CCGGCGCCGG)₂ and d(CGCGAATTCGCG)₂.

  Journal of molecular modeling 20110801

• Comparative study of alternating low-band-gap benzothiadiazole co-oligomers.

  Journal of fluorescence 20110701

• N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

  Journal of medicinal chemistry 20110623

• Phenoxazine dyes for dye-sensitized solar cells: relationship between molecular structure and electron lifetime.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20110527

• 2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells.

  Proceedings of the Japan Academy. Series B, Physical and biological sciences 20110511

• Structure-function relationships of phenoxazine nucleosides for identification of mismatches in duplex DNA by fluorescence spectroscopy.

  Chembiochem : a European journal of chemical biology 20110307

• Rapid decrease of intracellular pH associated with inhibition of Na+/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one.

  Oncology reports 20110201

• Organometallic anticancer compounds.

  Journal of medicinal chemistry 20110113

• Phenoxazine based units--synthesis, photophysics and electrochemistry.

  Journal of fluorescence 20110101

• An ensemble and single-molecule fluorescence microscopy investigation of phase-separated monolayer films stained with Nile Red.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110101

• Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro.

  Lipids in health and disease 20110101

• A new way for synthesis of phenoxazine and diphenoxazine derivatives via electrochemical method.

  Chemical & pharmaceutical bulletin 20110101

• Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.

  Molecular neurodegeneration 20110101

• Drug-resistant tuberculosis: emerging treatment options.

  Clinical pharmacology : advances and applications 20110101

• Chemical fate and mutagenic formation potentials of phenothiazine and related compounds during water chlorination.

  The Journal of toxicological sciences 20101201

• Investigations on the photoreactions of phenothiazine and phenoxazine in presence of 9-cyanoanthracene by using steady state and time resolved spectroscopic techniques.

  Journal of fluorescence 20100901

• Photophysical and structural properties of the fluorescent nucleobase analogues of the tricyclic cytosine (tC) family.

  Physical chemistry chemical physics : PCCP 20100821

• Structure and antibacterial activity of the silver(I) complex of 2-aminophenoxazine-3-one.

  Metallomics : integrated biometal science 20100801

• Palladium-catalyzed domino C-C/C-N coupling using a norbornene template: synthesis of substituted benzomorpholines, phenoxazines, and dihydrodibenzoxazepines.

  The Journal of organic chemistry 20100521

• In vitro antibacterial activity of Phx-3 against Helicobacter pylori.

  Biological & pharmaceutical bulletin 20100101

• Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.

  Journal of pharmacological sciences 20100101

• Development of an alcohol dehydrogenase biosensor for ethanol determination with toluidine blue O covalently attached to a cellulose acetate modified electrode.

  Sensors (Basel, Switzerland) 20100101

• Environmentally sensitive fluorescent sensors based on synthetic peptides.

  Sensors (Basel, Switzerland) 20100101

• A comprehensive review of glucose biosensors based on nanostructured metal-oxides.

  Sensors (Basel, Switzerland) 20100101

• Molecular recognition of cationic phenothiazinium and phenoxazinium dyes with pi-extended 2'-deoxyadenosine nucleotides.

  Chemical communications (Cambridge, England) 20091128

• Tuning of phenoxazine chromophores for efficient organic dye-sensitized solar cells.

  Chemical communications (Cambridge, England) 20091107

• Novel oxidative electrophilic coupling reactions of phenoxazine derivatives with MBTH and their applications to spectrophotometric determination of residual chlorine in drinking water and environmental water samples.

  Journal of hazardous materials 20091015

• Novel reactivity of dibenzothiophene monooxygenase from Bacillus subtilis WU-S2B.

  Bioscience, biotechnology, and biochemistry 20090901

• Laccase-mediated synthesis of novel substituted phenoxazine chromophores featuring tuneable water solubility.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20090817

• Intensification of biocatalytical processes by synergistic substrate conversion. Fungal peroxidase catalyzed N-hydroxy derivative oxidation in presence of 10-propyl sulfonic acid phenoxazine.

  Applied biochemistry and biotechnology 20090801

• Photosensitization of ruthenium nitrosyls to red light with an isoelectronic series of heavy-atom chromophores: experimental and density functional theory studies on the effects of O-, S- and Se-substituted coordinated dyes.

  Inorganic chemistry 20090720

• Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.

  Journal of neurochemistry 20090701

• Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells.

  Journal of pharmacological sciences 20090501

• Apoptosis induced by acrylamide is suppressed in a 21.5% fat diet through caspase-3-independent pathway in mice testis.

  Toxicology mechanisms and methods 20090301

• CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy.

  Molecular cancer therapeutics 20090201

• Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.

  PloS one 20090101

• Pro-oxidant effects of phenothiazine and phenoxazine on erythrocytes in the presence of peroxyl radical.

  Journal of biochemical and molecular toxicology 20090101

• Redmond Red as a redox probe for the DNA-mediated detection of abasic sites.

  Bioconjugate chemistry 20081119

• Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase.

  Archives of biochemistry and biophysics 20081015

• Driving forces for the mutual conversions between phenothiazines and their various reaction intermediates in acetonitrile.

  The journal of physical chemistry. B 20080918

• Dye-polyoxometalate composite films: self-assembly, thermal and photochemical properties.

  Journal of colloid and interface science 20080801

• Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular pH caused by phenoxazine derivatives.

  Oncology reports 20080501

• Substitutional disorder in the substituted nixantphos ligand C(39)H(32)Br(0.27)Cl(0.73)NOP(2).

  Acta crystallographica. Section E, Structure reports online 20080501

• 4,6-Bis(diphenyl-phosphino)phenoxazine (nixantphos).

  Acta crystallographica. Section E, Structure reports online 20080401

• Phenoxazine derivatives inactivate human cytomegalovirus, herpes simplex virus-1, and herpes simplex virus-2 in vitro.

  Journal of pharmacological sciences 20080301

• New insight for fluoroquinophenoxazine derivatives as possibly new potent topoisomerase I inhibitor.

  Bioorganic & medicinal chemistry letters 20080215

• Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis.

  Journal of neuro-oncology 20080201

• Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo.

  Oncology reports 20080101

• Plasmid loss in plasmid-carrying strains of Escherichia coli treated with phenoxazines and an approach to study their DNA binding properties.

  Nucleosides, nucleotides & nucleic acids 20080101

• Compatible solute influence on nucleic acids: many questions but few answers.

  Saline systems 20080101

• Novel oxidative coupling reactions of cisapride or metaclopramide with phenoxazines and their applications in the determination of nitrite at trace level in environmental samples.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071101

• Binding affinities of oligonucleotides and PNAs containing phenoxazine and G-clamp cytosine analogues are unusually sequence-dependent.

  Organic letters 20071025

• Novel reactions for simple and sensitive spectrophotometric determination of nitrite.

  Talanta 20070615

• Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes.

  Archives of biochemistry and biophysics 20070515

• Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.

  Journal of medicinal chemistry 20070503

• Antioxidants determination with laccase.

  Talanta 20070430

• Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.

  Bioorganic & medicinal chemistry 20070301

• Caspase-independent cell death revealed in human gastric cancer cell lines, MKN45 and KATO III treated with phenoxazine derivatives.

  Oncology reports 20070201

• Phenoxazine derivatives 2-amino-4,4alpha-dihydro-4alpha-phenoxazine-3-one and 2-aminophenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell line NB-1 cells.

  Biological & pharmaceutical bulletin 20070201

• Mechanisms of the inhibitory effects of a phenoxazine compound, 2-amino-4,4 alpha-dihydro-4 alpha-7-dimethyl-3H-phenoxazine-3-one, on the contraction of the smooth muscle of the guinea pig taenia cecum.

  Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20070201

• Aqueous solubility data for pressurized hot water extraction for solid heterocyclic analogs of anthracene, phenanthrene and fluorene.

  Journal of chromatography. A 20070126

• Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-251 MG.

  Oncology reports 20070101

• [Evaluation of the trichellocidal activity of lantirin (IMP-17)].

  Meditsinskaia parazitologiia i parazitarnye bolezni 20070101

• Quantitative structure-cytotoxicity relationship analysis of phenoxazine derivatives by semiempirical molecular-orbital method.

  Anticancer research 20070101

• Tumor-specificity and type of cell death induced by phenoxazines.

  Anticancer research 20070101

• Inhibition of choline oxidase by quinoid dyes.

  Journal of enzyme inhibition and medicinal chemistry 20061201

• 2-aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice.

  Biological & pharmaceutical bulletin 20061101

• A study on the perturbation of model lipid membranes by phenoxazines.

  Bioorganic & medicinal chemistry 20060901

• Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers.

  Journal of medicinal chemistry 20060824

• The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites.

  Chemistry & biology 20060801

• A long-wavelength fluorescent glucose biosensor based on bioconjugates of galactose/glucose binding protein and Nile Red derivatives.

  Diabetes technology & therapeutics 20060601

• Inhibition of calmodulin-dependent cyclic AMP phosphodiesterase by phenoxazines.

  Biochemical and biophysical research communications 20060414

• Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.

  Oncology reports 20060401

• Benzo[a]phenoxazines: a new group of potent P-glycoprotein inhibitors.

  In vivo (Athens, Greece) 20060101

• Synthesis of thiol-reactive, long-wavelength fluorescent phenoxazine derivatives for biosensor applications.

  Bioconjugate chemistry 20060101

• Bioinorganic chemistry in thyroid gland: effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions.

  Bioinorganic chemistry and applications 20060101

• Chlamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative.

  Journal of medical microbiology 20051201

• Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.

  The Journal of biological chemistry 20050909

• A phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha-7-dimethyl-3H-phenoxazine-3-one reverses the phenylephrine or high-K+ induced contraction of smooth muscles in rat aorta and guinea pig tenia cecum.

  Biological & pharmaceutical bulletin 20050801

• Synergistic enhancement of TRAIL- and tumor necrosis factor alpha-induced cell death by a phenoxazine derivative.

  Molecular cancer therapeutics 20050701

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• 2-amino-phenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.

  Biological & pharmaceutical bulletin 20050501

• Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazines, 2-amino-4,4 alpha-dihydro-4 alpha-7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4 alpha-dihydro-4 alpha-8-dimethyl-2H-phenoxazine-2-one.

  Biological & pharmaceutical bulletin 20050501

• Reactions of excited states of phenoxazin-3-one dyes with amino acids.

  Photochemistry and photobiology 20050101

• Anthracyclines, proteasome activity and multi-drug-resistance.

  BMC cancer 20050101

• Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.

  Biopharmaceutics & drug disposition 20041001

• Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria.

  The Tohoku journal of experimental medicine 20040501

• The phenoxazine derivative Phx-1 suppresses IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells.

  Journal of pharmacological sciences 20040301

• Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models.

  Pharmacological research 20040201

• Interaction of 2-chloro-N10-substituted phenoxazine with DNA and effect on DNA melting.

  Nucleosides, nucleotides & nucleic acids 20040101

• Screen-printed electrodes with electropolymerized Meldola Blue as versatile detectors in biosensors.

  Biosensors & bioelectronics 20030501

• Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.

  Journal of medicinal chemistry 20030410

• Photochemical and thermal transformations of 1-aryloxy-2- and 4-azidoanthraquinones.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20030404

• A novel phenoxazine derivative suppresses proliferation of human endometrial adenocarcinoma cell lines, inducing G2M accumulation and apoptosis.

  Oncology reports 20030101

• Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.

  Antisense & nucleic acid drug development 20030101

• High-affinity peptide nucleic acid oligomers containing tricyclic cytosine analogues.

  Organic letters 20021212

• A novel phenoxazine derivative suppresses surface IgM expression in DT40 B cell line.

  British journal of pharmacology 20021101

• Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis.

  Journal of cancer research and clinical oncology 20020701

• Iodine(V) reagents in organic synthesis. Part 1. Synthesis of polycyclic heterocycles via Dess-Martin periodinane-mediated cascade cyclization: generality, scope, and mechanism of the reaction.

  Journal of the American Chemical Society 20020313

• Effects of novel phenoxazine compounds, 2-amino-4, 4a-dihydro-4alpha, 7-dimethyl-3H-phenoxazine-3-one and 3-amino-1, 4alpha-dihydro-4alpha, 8-dimethyl-2H-phenoxazine-2-one on proliferation of phytohemagglutinin- or anti-human IgM-activated human peripheral blood mononuclear cells.

  The Tohoku journal of experimental medicine 20020301

• Nuclease resistance of oligonucleotides containing the tricyclic cytosine analogues phenoxazine and 9-(2-aminoethoxy)-phenoxazine ('G-clamp') and origins of their nuclease resistance properties.

  Biochemistry 20020129

• Oxidation of phenothiazine and phenoxazine by Cunninghamella elegans.

  Xenobiotica; the fate of foreign compounds in biological systems 20011101

• Protective activity of aromatic amines and imines against oxidative nerve cell death.

  Biological chemistry 20011101

• (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.

  Journal of medicinal chemistry 20010802

• Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010301